Pricing Transparency Statement

This information is provided to comply with section 45 CFR 170.523(k)(1) of the Principles of proper conduct for ONC-ACBs as determined by the Office of the National Coordinator for Health Information Technology in the Department of Health and Human Services.

Pricing Transparency Statement
Vendor/Developer: Medsphere Systems Corporation
Certified EHR Name: OpenVista CareVue
Certified EHR Version: 1.7
InfoGard Certification #: IG-2449-14-0012 (inpatient) IG-2449-14-0019 (ambulatory)
Certification Date: April 8, 2014 (inpatient) June 26, 2014 (ambulatory)
Certification Criteria:
  • 170.314(a)(1) COMPUTERIZED PROVIDER ORDER ENTRY
  • 170.314(a)(2) DRUG-DRUG, DRUG-ALLERGY INTERACTION CHECKS
  • 170.314(a)(3) DEMOGRAPHICS
  • 170.314(a)(4) VITAL SIGNS, BODY MASS INDEX, AND GROWTH CHARTS
  • 170.314(a)(5) PROBLEM LIST
  • 170.314(a)(6) MEDICATION LIST
  • 170.314(a)(7) MEDICATION ALLERGY LIST
  • 170.314(a)(8) CLINICAL DECISION SUPPORT
  • 170.314(a)(9) ELECTRONIC NOTES
  • 170.314(a)(10) DRUG-FORMULARY CHECKS
  • 170.314(a)(11) SMOKING STATUS
  • 170.314(a)(12) IMAGE RESULTS
  • 170.314(a)(13) FAMILY HEALTH HISTORY
  • 170.314(a)(14) PATIENT LIST CREATION
  • 170.314(a)(15) PATIENT-SPECIFIC EDUCATION RESOURCES
  • 170.314(a)(16) ELECTRONIC MEDICATION ADMINISTRATION RECORD
  • 170.314(a)(17) ADVANCE DIRECTIVES
  • 170.314(b)(1) TRANSITIONS OF CARE - RECEIVE, DISPLAY, AND INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES
  • 170.314(b)(2) TRANSITIONS OF CARE - CREATE AND TRANSMIT TRANSITION OF CARE/REFERRAL SUMMARIES
  • 170.314(b)(3) ELECTRONIC PRESCRIBING
  • 170.314(b)(4) CLINICAL INFORMATION RECONCILIATION
  • 170.314(b)(5) INCORPORATE LABORATORY TESTS AND VALUES/RESULTS
  • 170.314(b)(6) TRANSMISSION OF ELECTRONIC LABORATORY TESTS AND VALUES/RESULTS TO AMBULATORY PROVIDERS
  • 170.314(b)(7) DATA PORTABILITY
  • 170.314(c)(1) CLINICAL QUALITY MEASURES - CAPTURE AND EXPORT
  • 170.314(c)(2) CLINICAL QUALITY MEASURES - IMPORT AND CALCULATE
  • 170.314(c)(3) CLINICAL QUALITY MEASURES - ELECTRONIC SUBMISSION
  • 170.314(d)(1) AUTHENTICATION, ACCESS CONTROL, AND AUTHORIZATION
  • 170.314(d)(2) AUDITABLE EVENTS AND TAMPER-RESISTANCE
  • 170.314(d)(3) AUDIT REPORT(S)
  • 170.314(d)(4) AMENDMENTS
  • 170.314(d)(5) AUTOMATIC LOG-OFF
  • 170.314(d)(6) EMERGENCY ACCESS
  • 170.314(d)(7) END-USER DEVICE ENCRYPTION
  • 170.314(d)(8) INTEGRITY
  • 170.314(e)(1) VIEW, DOWNLOAD, AND TRANSMIT TO 3RD PARTY
  • 170.314(f)(1) IMMUNIZATION INFORMATION
  • 170.314(f)(2) TRANSMISSION TO IMMUNIZATION REGISTRIES
  • 170.314(f)(3) TRANSMISSION TO PUBLIC HEALTH AGENCIES - SYNDROMIC SURVEILLANCE
  • 170.314(f)(4) TRANSMISSION OF REPORTABLE LABORATORY TESTS AND VALUES/RESULTS
  • 170.314(g)(2) AUTOMATED MEASURE CALCULATION
  • 170.314(g)(3) SAFETY-ENHANCED DESIGN
  • 170.314(g)(4) QUALITY MANAGEMENT SYSTEM
Clinical Quality Measures (inpatient):
  • CMS9 EXCLUSIVE BREAST MILK FEEDING
  • CMS31 EHDI-1A - HEARING SCREENING PRIOR TO HOSPITAL DISCHARGE
  • CMS71 STROKE-3 ISCHEMIC STROKE – ANTICOAGULATION THERAPY FOR ATRIAL FIBRILLATION/FLUTTER
  • CMS72 STROKE-5 ISCHEMIC STROKE – ANTITHROMBOTIC THERAPY BY END OF HOSPITAL DAY TWO
  • CMS73 VTE-3 VTE PATIENTS WITH ANTICOAGULATION OVERLAP THERAPY
  • CMS91 STROKE-4 ISCHEMIC STROKE – THROMBOLYTIC THERAPY
  • CMS100 AMI-2-ASPIRIN PRESCRIBED AT DISCHARGE FOR AMI
  • CMS102 STROKE-10 ISCHEMIC OR HEMORRHAGIC STROKE – ASSESSED FOR REHABILITATION
  • CMS104 STROKE-2 ISCHEMIC STROKE – DISCHARGED ON ANTI-THROMBOTIC THERAPY
  • CMS105 STROKE-6 ISCHEMIC STROKE – DISCHARGED ON STATIN MEDICATION
  • CMS107 STROKE-8 ISCHEMIC OR HEMORRHAGIC STROKE – STROKE EDUCATION
  • CMS108 VENOUS THROMBOEMBOLISM (VTE)-1 VTE PROPHYLAXIS
  • CMS109 VTE-4 VTE PATIENTS RECEIVING UNFRACTIONATED HEPARIN (UFH) WITH DOSAGES/PLATELET COUNT MONITORING BY PROTOCOL (OR NOMOGRAM)
  • CMS110 VTE-5 VTE DISCHARGE INSTRUCTIONS
  • CMS113 PC-01 ELECTIVE DELIVERY PRIOR TO 39 COMPLETED WEEKS GESTATION
  • CMS114 VTE-6 INCIDENCE OF POTENTIALLY PREVENTABLE VTE
  • CMS190 VTE-2 INTENSIVE CARE UNIT (ICU) VTE PROPHYLAXIS

This Complete EHR is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.

OpenVista CareVue 1.7 is offered for an annual subscription fee. Travel and expenses may be incurred during the implementation and training phase of the deployment.

Recurring costs in addition to the annual subscription fee may include the following optional services:

  • Electronic prescribing – based upon number of prescribers
  • Patient portal and secure Direct messaging – based upon number of Direct addresses assigned to the organization.

Certain third party products and services may be required. These products may require hardware, separate licensing, and support fees. These are dependent on the final configuration and features chosen for implementation:

  • Lab interfaces:
    • Lab instrument interface software, if the customer has lab instruments that need to be interfaced to OpenVista
    • Interfaces to other systems such as laboratory information system (LIS), reference lab
  • Medical imaging:
    • Interface to PACS

Limitations that a user may encounter in the course of implementing and using OpenVista CareVue may include:

  • OpenVista CareVue uses Surescripts as the HISP for direct messaging. Surescripts is a member of DirectTrust, a non-profit association of health IT and health care provider organizations to support secure, interoperable health information exchange via the Direct message protocols. Users of OpenVista CareVue 1.7 can connect to any other member of DirectTrust (member list at https://www.directtrust.org/member-list/ ) or any HISP listed at http://surescripts.com/network-connections.
  • Healthcare providers who have not yet established a relationship of trust with Surescripts can be added by making a request to Medsphere.